NE BioGroup to Distribute Nonlinear's TotalLab Range
News Mar 01, 2006
Under the contract, NE BioGroup, will distribute Nonlinear’s TotalLab product range for analysis of 1D electrophoresis gels, throughout the US.
Nonlinear’s extended TotalLab range incorporates the TL100 general image analysis software and TL120 for comprehensive, automated analysis of 1D gel images.
Also included is the TL120 DM analysis solution, incorporating an enhanced database component to enable researchers to store and mine data across multiple experiments. All software will be available for both PC and Apple Mac users.
Lou Farrell, CEO of New England BioGroup, LLC, said, "We work very closely with our customers to ensure they have the best tools to advance their research and accelerate discovery."
"As such, the quality of Nonlinear’s TotalLab range makes it an extremely significant addition to our product portfolio. We are confident that life science researchers located in New England and the rest of the U.S. will benefit considerably through this agreement."
John Spreadbury, Group Sales and Marketing Director at Nonlinear Dynamics and CEO of Nonlinear USA Inc., said, "Continually evolving, the extended TotalLab range provides user-centric solutions."
"It is scientifically tailored to combine outstanding usability with incisive automated analysis features to benefit users, delivering a choice of products customisable to their level of research."
"The TotalLab software fully compliments NE BioGroup’s established portfolio of first-dimensional electrophoresis instrumentation and consumables."
"This factor, coupled with NE BioGroup’s excellent reputation in the US life sciences market made them a natural partner; we are delighted to be working with them."
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018